IBX 2.50% 3.9¢ imagion biosystems limited

Imagion Biosystems (ASX:IBX) enters trading halt ahead of breast cancer study, page-6

  1. 144 Posts.
    lightbulb Created with Sketch. 56
    I don't believe it will affect it to much on the basis that the announcement accompanying the raise info was extremely bullish - funds to fast track to phase II and commercialisation. In saying that cap. raises can lead to an initial decline - I wouldn't think it will be around long as the potential of the product is too high.


 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.